The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.8, 2013-08, pp. : 889-903

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Experimental Antiarrhythmic Targets: CaMKII Inhibition – Ready for Clinical Evaluation?

Current Medicinal Chemistry, Vol. 21, Iss. 11, 2014-04 ,pp. : 1299-1307

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacologic Management of Arrhythmias in Patients with Congenital Heart Disease

By Batra A.S. Luna C.F. Silka M.J.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 2, 2001-01 ,pp. : 91-103

Adis International

Access to resources Recommend Favorite

Primary prophylaxis best for preventing rheumatic heart disease

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 668, 2012-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Future Perspectives in the Pharmacological Treatment of Atrial Fibrillation and Ventricular Arrhythmias in Heart Failure

Current Pharmaceutical Design, Vol. 21, Iss. 8, 2015-03 ,pp. : 1011-1029

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Cardiomyocyte Ca2 Homeostasis in Heart Failure

Current Pharmaceutical Design, Vol. 21, Iss. 4, 2015-02 ,pp. : 431-448

Bentham Science Publishers

Access to resources Recommend Favorite